Skip to main content
Clinical Trials/ACTRN12614000194662
ACTRN12614000194662
Completed
未知

In children undergoing bladder catheterization, does oral sucrose compared to placebo, reduce pain and distress caused by the procedure?

Ralph Nanan0 sites40 target enrollmentFebruary 24, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Pain experienced during bladder catheterization.
Sponsor
Ralph Nanan
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 24, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ralph Nanan

Eligibility Criteria

Inclusion Criteria

  • Infants or children requiring bladder catheterisation for diagnosis of suspected urinary tract infection.
  • Have not achieved bladder control.

Exclusion Criteria

  • Unable to tolerate oral fluids. Unsuccessful first attempt at bladder catheterisation. Toilet trained. Oral sucrose is contraindicated (eg diabetic ketoacidosis). Altered neurological state (eg moribund, neurological conditions).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Analgesic efficacy of paravertebral dexmedetomidine in children undergoing renal surgerypostoperative analgesia for pediatric patients undergoing renal surgeryAnaesthesiology - AnaestheticsSurgery - Other surgeryRenal and Urogenital - Kidney disease
ACTRN12615000708550diab fuad hetta80
Active, not recruiting
Not Applicable
asal oxygen therapy during paediatric direct laryngoscopy and endotracheal intubation.Hypoxia (Desaturation)Anaesthesiology - Anaesthetics
ACTRN12613001101774Dr Paul Baker40
Recruiting
Not Applicable
Follow-up of infants and children surgically treated for an acquired laryngeal stenosis after endotracheal intubatioverworven luchtwegaandoeningenlarynxstenosisnarrowing of the upper airway
NL-OMON34296Erasmus MC, Universitair Medisch Centrum Rotterdam79
Completed
Phase 4
Prevention of renal and bladder damage in children with spina bifida by means of early injections with Botulinum-Toxin-A (Botox): a pilot study.Neurogenic bladder function disease in spina bifida patientsspastic bladder in spina bifida patients.100292991002930510004994
NL-OMON40616Erasmus MC, Universitair Medisch Centrum Rotterdam10
Active, not recruiting
Phase 1
Prevention of renal and bladder damage in children with spina bifida by means of early injections with Botulinum-Toxin-A (Botox): a pilot study.eurogenic bladder function disease in spina bifida patients.MedDRA version: 16.1Level: LLTClassification code 10030685Term: Open spina bifidaSystem Organ Class: 100000004850MedDRA version: 16.1Level: LLTClassification code 10041531Term: Spina bifida without mention of hydrocephalusSystem Organ Class: 100000004850MedDRA version: 16.1Level: LLTClassification code 10029280Term: Neurogenic bladder, not otherwise specifiedSystem Organ Class: 100000004857Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2013-003842-18-NLErasmus MC